Catalyst Wire Dossier Catalyst Wire Dossier

Entyvio

vedolizumab · Takeda
Drug timelines are a Plus or Pro feature.

46 regulatory and trial events tracked for Entyvio, covering 2014-05-20 to 2026-06-15. Get the full timeline:

Most recent: EMA Authorised: Entyvio (vedolizumab) — Takeda Pharma A/S

See pricing